Event Calendar Web
  • Main Image Navi

QIAGEN publishes information on directors' dealings as reported to the company and pursuant to regulations by the United States Securities and Exchange Commission (SEC), the Netherlands Authority for the Financial Markets (A-FM) pursuant to Section 2a Wmz 1996 and Art. 19. EU Directive No. 596/2014. 

Insider Trading Policy

Statement of Company Policy (PDF 1,48 MB)

Recent Transactions

* Cashless Exercise

1) According to a Rule 10b5-1 long-term Sales Plan ("Langzeitverkaufsvertrag").

2) Manfred Karobath, Stéphane Bancel, Metin Colpan, Ross L. Levine, Elaine R. Mardis, Lawrence A. Rosen, Elizabeth E. Tallett

3) “Sell to cover” transaction in which only the portion of the shares vested is sold required to cover expenses related to the receipt of the shares such as taxes, transaction costs.

a) Expiration date of underlying options due to Dr. Brandt's resignation from the Supervisory Board of QIAGEN N.V. after the Annual General Meeting: September 20, 2016.

b) A performance-based stock program was introduced for a small group of executives in November 2013. The vesting of shares in this program, and also percentages of shares granted, will be measured on the performance of QIAGEN over several years in terms of net sales, adjusted EBIT and QVA, a value creation measurement system related to ROIC and EVA. Program replaces stock option grants over period and contingent upon a commitment to mandatory minimum share ownership.

c) 10 year expiration date of underlying options: February 28, 2017.

d) Represents conversion of a portion of 2016 cash bonus into PSU.

e) Adjustments in holdings after synthetic share repurchase completed in January 2017 (every 27 issued QIAGEN shares were consolidated into 26 QIAGEN shares and a direct capital repayment of $1.04 for each of the 27 prior-reduction shares).   

f) 10 year expiration date of underlying options: April 25, 2017.

g) Grant is part of a performance-based stock program for a small group of executives. The vesting of shares in this program, and also percentage of shares granted, will be measured on the performance of QIAGEN in 2017 in terms of sales, adjusted operating income and adjusted free cash flow.


Name and Function

Date and Type

Financial Instrument

Amount
of
Shares

SEC

BAFin

A-FM

Peer M. Schatz
Managing Director
05/05/17 
Grant g)
Performance Stock Units

100,000

—— PDF  PDF
Roland Sackers
Managing Director
05/05/17 
Grant g)
Performance Stock Units

100,000

—— PDF PDF
Peer M. Schatz
Managing Director
05/01/17
Sale
Common Shares received through Release of Performance Stock Units
("Sell to Cover")

8,760

PDF PDF  PDF 
Peer M. Schatz
Managing Director
04/28/17 Common Shares received through Release of Performance Stock Units

18,387

——  PDF  PDF 
Manfred Karobath
Metin Colpan
Supervisory Director
04/26/17
Sale
Common Shares received through Release of Restricted Stock Units
("Sell to Cover")

284

PDF  PDF  PDF  
Manfred Karobath
Metin Colpan
Supervisory Director
04/25/17 Common Shares received through Release of Restricted Stock Units

538

——  PDF  PDF  
Peer M. Schatz
Managing Director
03/29/17
Sale
Common Shares received through Release of Performance Stock Units
("Sell to Cover")

345,053

PDF PDF PDF
  03/28/17 Common Shares received through Release of Performance Stock Units

717,907

——  PDF PDF
Peer M. Schatz
Managing Director
03/16/17
Sale
Common Shares received through Release of Performance Stock Units
("Sell to Cover")

6,079.92

PDF PDF PDF
  03/15/17
           
Common Shares received through Release of Performance Stock Units

12,454

—— PDF PDF
Roland Sackers
Managing Director
03/16- 03/17/17
Sale1)
Common Shares received through Release of Performance Stock Units

3,997

PDF PDF PDF
  03/15/17
           
Common Shares received through Release of Performance Stock Units

3,997

—— PDF PDF
Manfred Karobath
Metin Colpan
Supervisory Director
03/03/17 
Sale *1)f)
Stock Options
(Expiry: April 25, 2017)

1,942

PDF PDF PDF 
Manfred Karobath
Supervisory Director
03/07/17
Sale
Common Shares received through Release of Restricted Stock Units
("Sell to Cover")

3,422

PDF PDF PDF
  03/01/17 Common Shares received through Release of Restricted Stock Units

2,716

—— PDF PDF
  02/28/17 Common Shares received through Release of Restricted Stock Units

4,000

—— PDF PDF
Metin Colpan
Supervisory Director
03/02/17
Sale
Common Shares received through Release of Restricted Stock Units
("Sell to Cover")

1,439

PDF PDF PDF
  03/01/17 Common Shares received through Release of Restricted Stock Units

2,716

—— PDF PDF
Metin Colpan
Supervisory Director
03/01/17
Sale
Common Shares received through Release of Restricted Stock Units
("Sell to Cover")

2,119

PDF PDF PDF
  02/28/17
Common Shares received through Release of Restricted Stock Units

4,000

—— PDF PDF
Elizabeth E. Tallett 03/07/17
Sale
Common Shares received through Release of Restricted Stock Units
("Sell to Cover")

2,764

PDF PDF PDF 
  03/01/17 Common Shares received through Release of Restricted Stock Units 

2,716

—— PDF PDF
  02/28/17 Common Shares received through Release of Restricted Stock Units

4,000

—— PDF PDF
Stéphane Bancel
Supervisory Director
03/01/17
Sale
Common Shares received through Release of Restricted Stock Units
("Sell to Cover")

1,919

PDF PDF  PDF
  02/28/17 Common Shares received through Release of Restricted Stock Units

4,000

—— PDF  PDF 
Lawrence A. Rosen
Supervisory Director
03/01- 03/02/17
Sale1)
Common Shares received through Release of Restricted Stock Units

4,000

PDF PDF PDF 
  02/28/17
Common Shares received through Release of Restricted Stock Units

4,000

—— PDF PDF
Peer M. Schatz
Managing Director
03/02/17
Sale
Common Shares received through Release of Restricted Stock Units
("Sell to Cover")

111,456

PDF PDF PDF 
  03/01/17 Common Shares received through Release of Restricted Stock Units

232,590

—— PDF PDF
Peer M. Schatz
Managing Director
03/01/17
Sale
Common Shares received through Release of Restricted Stock Units
("Sell to Cover")

88,849

PDF PDF PDF
  02/28/17 Common Shares received through Release of Restricted Stock Units

185,204

—— PDF PDF
Roland Sackers
Managing Director
03/02/17
Sale1)
Common Shares received through Release of Restricted Stock Units

77,950

PDF PDF  PDF
03/01/17 Common Shares received through Release of Restricted Stock Units

77,950

—— PDF PDF
Roland Sackers
Managing Director
03/01- 03/02/17
Sale1)
Common Shares received through Release of Restricted Stock Units

46,537

PDF PDF PDF
02/28/17 Common Shares received through Release of Restricted Stock Units

46,537

—— PDF PDF 
All Supervisory Board Directors 2) 02/28/17 
Grant
Restricted Stock Units

10,732

—— PDF PDF
Peer Schatz
Managing Director
02/28/17 
Grant
Performance Stock Units

345,000

—— PDF PDF
Roland Sackers
Managing Director
02/28/17 
Grant
Performance Stock Units

86,075

—— PDF PDF 
Peer Schatz
Managing Director
02/16/17
Sale
Common Shares received through Release of Restricted and Performance Stock Units
("Sell to Cover")

22,123

PDF PDF PDF
Peer Schatz
Managing Director
02/15/17
           
Common Shares received through Release of Restricted and Performance Stock Units

47,357

 —— PDF PDF
Roland Sackers
Managing Director
02/16/17
Sale1)
Common Shares received through Release of Restricted and Performance Stock Units

15,160

PDF PDF PDF
Roland Sackers
Managing Director
02/15/17 Common Shares received through Release of Restricted and Performance Stock Units

15,160

 —— PDF PDF
Manfred Karobath
Supervisory Director
01/25/17 Common Shares
(Adjustment in Holdinge))

692

—— PDF PDF
Metin Colpan
Supervisory Director
01/25/17 Common Shares
(Adjustment in Holdinge))

135,519

—— PDF PDF
Elizabeth E. Tallett
Supervisory Director
01/25/17 Common Shares
(Adjustment in Holdinge))

187

—— PDF PDF
Peer Schatz
Managing Director
01/25/17 Common Shares
(Adjustment in Holdinge))

78,842.08

—— PDF PDF
Roland Sackers
Managing Director
01/25/17 Common Shares
(Adjustment in Holdinge))

742

—— PDF PDF
Roland Sackers
Managing Director
12/16/16
Grantd)
Performance Stock Units

23,419

—— PDF PDF 
Roland Sackers
Managing Director
12/01/16
Sale1)
Common Shares received through Release of Restricted Stock Units

9,729

PDF PDF PDF 
Roland Sackers
Managing Director
11/30/16  Common Shares received through Release of Restricted Stock Units

9,729

—— PDF PDF
Peer Schatz
Managing Director
11/25 - 11/28/16 
Sale *1)c)
Stock Options
(Expiry: February 28, 2017)

114,551

PDF PDF PDF 
Peer Schatz
Managing Director
10/31/16
Grantb)
Performance Stock Units

460,220

——
PDF
PDF
Roland Sackers
Managing Director
10/31/16
Grantb)
Performance Stock Units

144,809

——
PDF PDF
Werner Brandt
Supervisory Director
06/21/16 Common Shares received through Release of Restricted Stock Units

19,369

——  ——   PDF
Werner Brandt
Supervisory Director
06/07/16 
Sale *a)
Stock Options
(Expiry: September 20, 2016)

4,855

 PDF ——  PDF